Sns Financial Group, LLC Boston Scientific Corp Transaction History

Sns Financial Group, LLC

$912 Million
Q1 2024

A detailed history of Sns Financial Group, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Sns Financial Group, LLC holds 4,665 shares of BSX stock, worth $357,105. This represents 0.03% of its overall portfolio holdings.

Number of Shares

4,665

Previous 4,654 0.24%

Holding current value

$357,105

Previous $269,000 18.59%

% of portfolio

0.03%

Previous 0.03%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	BUY	$57.6 - $68.62 $633 - $754	11 Added 0.24%	4,665 $319,000
Q4 2023 Jan 22, 2024	SELL	$48.64 - $57.81 $2,042 - $2,428	-42 Reduced 0.89%	4,654 $269,000
Q3 2023 Oct 19, 2023	BUY	$50.19 - $54.68 $552 - $601	11 Added 0.23%	4,696 $247,000
Q2 2023 Jul 17, 2023	SELL	$49.72 - $54.64 $447 - $491	-9 Reduced 0.19%	4,685 $253,000
Q1 2023 Apr 28, 2023	BUY	$45.09 - $50.03 $1,668 - $1,851	37 Added 0.79%	4,694 $234,000

Q4 2022 Jan 25, 2023	BUY	$39.56 - $47.22 $184,230 - $219,903	4,657 New	4,657 $0
Q2 2022 Jul 22, 2022	SELL	$35.24 - $47.1 $161,504 - $215,859	-4,583 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$40.9 - $45.1 $187,444 - $206,693	4,583 New	4,583 $203,000
Q1 2020 May 07, 2020	SELL	$25.83 - $45.71 $120,186 - $212,688	-4,653 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$37.87 - $45.37 $176,209 - $211,106	4,653 New	4,653 $211,000
Q4 2018 Feb 05, 2019	SELL	$31.73 - $39.04 $219,761 - $270,391	-6,926 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$26.84 - $34.32 $185,893 - $237,700	6,926 New	6,926 $226,000

Others Institutions Holding BSX

# of Institutions

1,321

Shares Held

1.17B

Call Options Held

5.92M

Put Options Held

5.75M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $110B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sns Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sns Financial Group, LLC with notifications on news.

Account

Sns Financial Group, LLC Boston Scientific Corp Transaction History